Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.0700 (-4.34%) ($5.0300 - $5.3300) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.68% (three month average) | RSI | 65 | Latest Price | $5.0700(-4.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.5% a day on average for past five trading days. | Weekly Trend | CEMI advances 4.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) SIL(22%) GDXJ(21%) INDA(21%) GDX(19%) SLV(19%) | Factors Impacting CEMI price | CEMI will decline at least -5.34% in a week (0% probabilities). URA(-34%) UUP(-29%) USO(-21%) XOP(-20%) XHB(-19%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.34% (StdDev 10.68%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
5 Day Moving Average | $5.11(-0.78%) | 10 Day Moving Average | $5.11(-0.78%) | 20 Day Moving Average | $4.67(8.57%) | To recent high | -64.3% | To recent low | 1.4% | Market Cap | $102m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |